Stay updated on the progress of our pioneering endeavors.
On September 3, 2022, Beijing Grand Johamu Pharmaceutical Co., Ltd, one member enterprise in the respiratory and anti-severe-infection plate owned by Grand Pharma Group Co., Ltd. (0512.HK) (briefly known as Grand Pharma), held a product launch event for two globally innovative…
On August 19, 2022, the opening ceremony of Grand Pharma Wuhan Optics Valley R&D Center (“the Center”) and Extensive Intervention Production and R&D Platform (“the Platform”) was held at Donghu High-tech District Precision Medicine Industry Base…
On June 19, 2022, Grandpharma (0512.HK) announced that a "nuclear weapon" innovative medical product to treat liver malignant tumors -- SIR-Spheres® yttrium-90 microsphere injections (trademark in Chinese charters: 易甘泰®, read as “Yigantai”) …
On April 8, 2022, a new production base (West High-tech Zone) for blood products of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.("Yuanda Shuyang"), a wholly-owned subsidiary of Yuanda Life Science Group Co., Ltd, was officially put into operation,
On December 26th , during the morning hours, the grand opening ceremony dubbed as "Southbound Rebirth" for the Chengdu Grand Shopping Center was officially launched. With a refurbished fully upgraded setup and a fresh stance, Chengdu Grand Shopping Center…
On November 5, 2021, the 4th China International Import Expo was held in Shanghai. China Grand Pharmaceutical and Healthcare Holdings Ltd. attended with two innovative products - HeartLight X3, a medical device for the treatment of atrial fibri